Post-earnings recap
Reported
Tue, Feb 2, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corporation reported an EPS of $0.62, which was below expectations, but the stock still rose by nearly 13%. This positive stock reaction may be attributed to investor optimism or other factors not detailed in the earnings call. Without additional guidance or commentary from management, it's unclear how the company plans to address the EPS miss moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | -8.55% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.